Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Grunebaum

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Annales De Radiologie|January 1, 1994
[Comparative thrombotic risk of two contrast agents in coronary angiography]F Wolff, M Zupan, P Klero de Rosbo, et al.
The American Journal of Gastroenterology|May 12, 1998
Significance of diminished factor XIII in Crohn's diseaseP Chamouard, L Grunebaum, M L Wiesel, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1991
The catalytic role of anionic phospholipids in the activation of protein C by factor Xa and expression of its anticoagulant function in human plasmaJ M Freyssinet, F Toti-Orfanoudakis, C Ravanat, et al.
European Journal of Gastroenterology & Hepatology|December 1, 1995
Prothrombin fragment 1 + 2 and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel diseasesP Chamouard, L Grunebaum, M L Wiesel, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 1, 1994
[Von Willebrand factor in coronary disease]P Soskin, M L Wiesel, J M Mossard, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 18, 2017
Prognostic factors of hemorrhagic complications after oxaliplatin-based hyperthermic intraperitoneal chemotherapy: Toward routine preoperative dosage of Von Willebrand factor?J-B Delhorme, L Sattler, F Severac, et al.
The New England Journal of Medicine|March 14, 1985
Genetic screening for hemophilia A (classic hemophilia) with a polymorphic DNA probeI Oberle, G Camerino, R Heilig, et al.
The Biochemical Journal|July 15, 1989
Activation of human protein C by blood coagulation factor Xa in the presence of anionic phospholipids. Enhancement by sulphated polysaccharidesJ M Freyssinet, M L Wiesel, L Grunebaum, et al.
Annales De Cardiologie Et D'Angeiologie|March 9, 2007
[Platelet responsiveness to clopidogrel in patients with coronary syndrome. Comparison of platelet aggregation induced by ADP and flow cytometric analysis of intraplatelet VASP phosphorylation]O Morel, C Viellard, A Faure, et al.
Archives Francaises De Pediatrie|August 1, 1992
[Gray platelet syndrome]P Lutz, A Roth-Pougheon, M L Wiesel, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Annales De Radiologie|January 1, 1994
[Comparative thrombotic risk of two contrast agents in coronary angiography]F Wolff, M Zupan, P Klero de Rosbo, et al.
The American Journal of Gastroenterology|May 12, 1998
Significance of diminished factor XIII in Crohn's diseaseP Chamouard, L Grunebaum, M L Wiesel, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1991
The catalytic role of anionic phospholipids in the activation of protein C by factor Xa and expression of its anticoagulant function in human plasmaJ M Freyssinet, F Toti-Orfanoudakis, C Ravanat, et al.
European Journal of Gastroenterology & Hepatology|December 1, 1995
Prothrombin fragment 1 + 2 and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel diseasesP Chamouard, L Grunebaum, M L Wiesel, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 1, 1994
[Von Willebrand factor in coronary disease]P Soskin, M L Wiesel, J M Mossard, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 18, 2017
Prognostic factors of hemorrhagic complications after oxaliplatin-based hyperthermic intraperitoneal chemotherapy: Toward routine preoperative dosage of Von Willebrand factor?J-B Delhorme, L Sattler, F Severac, et al.
The New England Journal of Medicine|March 14, 1985
Genetic screening for hemophilia A (classic hemophilia) with a polymorphic DNA probeI Oberle, G Camerino, R Heilig, et al.
The Biochemical Journal|July 15, 1989
Activation of human protein C by blood coagulation factor Xa in the presence of anionic phospholipids. Enhancement by sulphated polysaccharidesJ M Freyssinet, M L Wiesel, L Grunebaum, et al.
Annales De Cardiologie Et D'Angeiologie|March 9, 2007
[Platelet responsiveness to clopidogrel in patients with coronary syndrome. Comparison of platelet aggregation induced by ADP and flow cytometric analysis of intraplatelet VASP phosphorylation]O Morel, C Viellard, A Faure, et al.
Archives Francaises De Pediatrie|August 1, 1992
[Gray platelet syndrome]P Lutz, A Roth-Pougheon, M L Wiesel, et al.
Pageof 5